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In 2006, a case of H-type bovine spongiform encephalopathy (BSE-H) was diagnosed 
in a cow that was associated with a heritable polymorphism in the bovine prion protein 
gene (PRNP) resulting in a lysine for glutamate amino acid substitution at codon 211 
(called E211K) of the prion protein. Although the prevalence of this polymorphism is 
low, cattle carrying the K211 allele may be predisposed to rapid onset of BSE-H when 
exposed or to the potential development of a genetic BSE. This study was conducted 
to better understand the relationship between the K211 polymorphism and its effect on 
BSE phenotype. BSE-H from the US 2006 case was inoculated intracranially (IC) in one 
PRNP wild-type (EE211) calf and one EK211 calf. In addition, one wild-type calf and 
one EK211 calf were inoculated IC with brain homogenate from a US 2003 classical 
BSE case. All cattle developed clinical disease. The survival time of the E211K BSE-H 
inoculated EK211 calf (10 months) was shorter than the wild-type calf (18 months). This 
genotype effect was not observed in classical BSE inoculated cattle (both 26 months). 
Significant changes in retinal function were observed in H-type BSE challenged cattle 
only. Cattle challenged with the same inoculum showed similar severity and neuroana-
tomical distribution of vacuolation and disease-associated prion protein deposition in the 
brain, though differences in neuropathology were observed between E211K BSE-H and 
classical BSE inoculated animals. Western blot results for brain tissue from challenged 
animals were consistent with the inoculum strains. This study demonstrates that the 
phenotype of E211K BSE-H remains stable when transmitted to cattle without the K211 
polymorphism, and exhibits a number of features that differ from classical BSE in both 
wild-type and heterozygous EK211 animals.
Keywords: bovine spongiform encephalopathy, brain diseases, cattle, e211K, prion protein, transmissible 
spongiform encephalopathy
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inTrODUcTiOn
The transmissible spongiform encephalopathies (TSEs) are a 
group of fatal neurological diseases associated with the post-
translational conversion of the cellular form of the prion protein 
(PrPC) to a more protease-resistant isoform (PrPSc) (1, 2). Prion 
protein gene (PRNP) polymorphisms can alter the amino 
acid sequence and, therefore, the post-translational folding 
properties of PrPC, leading to variable susceptibility to infec-
tion or spontaneous emergence of prion disease. A number of 
disease-associated PRNP polymorphisms have been described 
for human prion diseases. Of these, codon 129 has a strong 
influence on susceptibility to acquired, sporadic, and familial 
prion disease, and the E200K mutation is the most frequent 
PRNP mutation associated with familial Creutzfeldt–Jakob 
disease (fCJD) (3, 4).
Bovine spongiform encephalopathy (BSE) was first identified 
in the late 1980s in cattle in the United Kingdom (5). Subsequent 
epidemiological investigations suggested transmission through 
exposure to feedstuffs contaminated with infectious ruminant-
derived protein (6, 7). In 2006, a case of H-type BSE (BSE-H) 
was detected in the United States (U.S.) in an animal with a novel 
polymorphism in PRNP associated with a substitution of lysine 
for glutamate at codon 211 (E211K) (8). It was subsequently 
discovered that the only living offspring of this cow also car-
ried the E211K polymorphism, demonstrating that the allele is 
heritable and homologous to the E200K mutation in sporadic/
genetic Creutzfeldt–Jakob disease (9). Intracranial challenge 
of an EK211 calf with brain homogenate from the 2006 U.S. 
BSE-H case (i.e., its granddam) resulted in rapid development 
of BSE with clinical and pathological features consistent with 
BSE-H (10).
Bovine spongiform encephalopathy in cattle can be differenti-
ated into three types based on the apparent molecular mass of the 
three prion protein fragments visualized on a western immuno-
blot. In classical BSE (BSE-C), the BSE type associated with the 
majority of BSE cases, including those in the United Kingdom 
BSE epizootic, the non-glycosylated PrPSc band migrates at 
~17 kDa. In atypical BSEs, the non-glycosylated PrPSc band runs 
0.5  kDa lower in low-type BSE (BSE-L) or 1–2  kDa higher in 
high-type BSE (BSE-H), when compared to BSE-C (11–15). In 
addition to differences in western blot migration pattern, the 
epidemiology of classical and atypical BSE cases are different. 
Most cases of atypical BSE occur in animals 8 years and older (16) 
while the risk of detection of C-BSE is highest at 5–6 years of age 
(17–19). Atypical BSE cases occur at a very low prevalence, have 
been reported worldwide, including in countries that are free of 
BSE-C, and there is a lack of epidemiologic links to other TSEs, 
leading to the hypothesis that they are sporadic diseases (20).
The purpose of this study was to investigate the effect of 
the K211 polymorphism on BSE phenotype. To test this, brain 
homogenate from the U.S. 2006 H-type BSE case bearing the 
E211K polymorphism was inoculated into wild-type (EE211) 
calves and EK211 calves. Genotype matched animals were 
inoculated with BSE-C to test whether the K211 allele could 
affect the molecular profile and mask the appearance of feed-
borne BSE-C.
MaTerials anD MeThODs
ethics statement
This experiment was carried out in accordance with the Guide 
for the Care and Use of Laboratory Animals, 8th edition (Institute 
of Laboratory Animal Resources, National Academy of Sciences, 
WA, USA) and the Guide for the Care and Use of Agricultural 
Animals in Research and Teaching (Federation of Animal Science 
Societies, Champaign, IL, USA). The protocol was approved by 
the Institutional Animal Care and Use Committee at the National 
Animal Disease Center (protocol number: 3985).
animals and Procedures
Two EK211 calves and two wild-type (EE211) calves were gener-
ated by embryo transfer from the only known offspring of the 
US 2006 atypical BSE case (9). Genotypes were confirmed by 
sequencing of the PRNP (9).
The BSE-H inoculum was prepared from brain homogenate 
from the brainstem of the U.S. 2006 atypical BSE case possess-
ing the E211K PRNP polymorphism. The BSE-C inoculum was 
prepared from brain homogenate from a U.S. classical BSE case 
that was diagnosed in 2003 (21).
At ~2 months of age one EK211 calf and one wild-type calf 
were inoculated intracranially (IC) with 1  ml of a 10% (w/v) 
homogenate of the BSE-H inoculum. In addition, one EK211 calf 
and one wild-type calf were inoculated IC with 1 ml of a 10% 
(w/v) homogenate of the BSE-C inoculum.
Intracranial inoculations were performed as described previ-
ously (10). Briefly, each calf was sedated with xylazine, the frontal 
area was clipped and scrubbed, a 1  cm midline incision was 
made in the skin slightly caudal to the junction of the parietal 
and frontal bones, and a 1  mm hole was drilled through the 
calvarium. A 22-gage spinal needle was advanced through the 
hole perpendicular to the frontal bones until the tip of the needle 
made contact with the opposite (bottom) side of the calvarium. 
The inoculum was slowly injected as the needle was withdrawn 
through the brain. The skin was closed with tissue glue (Vetbond, 
3M, St. Paul, MN, USA).
Calves were observed daily for clinical signs of disease and 
euthanized when unequivocal signs of TSE (see Results) were 
noted. Two sets of tissue samples were collected comprising 
representative sections of liver, kidney, spleen, skin, striated 
muscles (heart, tongue, diaphragm, and masseter), thyroid 
gland, turbinates, trachea, lung, esophagus, rumen, reticulum, 
omasum, abomasum, small intestine, including ileum, adrenal 
gland, pancreas, urinary bladder, lymph nodes (retropharyn-
geal, prescapular, mesenteric, and popliteal), tonsils (palatine 
and nasopharyngeal), nerves (sciatic, optic, and trigeminal), 
pituitary gland, trigeminal ganglion, brain (cerebral cortex, 
cerebellum, midbrain, including superior colliculus, brainstem 
including obex), spinal cord (cervical, thoracic, lumbar), and eye 
were collected.
The first set was collected into 10% buffered formalin (globes 
were fixed in Bouin’s fixative), embedded in paraffin wax, and 
sectioned at 5 μm for staining with hematoxylin and eosin (HE) 
and immunolabeling with anti-prion protein antibodies. The 
second set of tissues was frozen.
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electroretinography
Electroretinography was performed on challenged cattle as 
previously described (22) prior to inoculation, and at 6, 9, and 
12  months post inoculation (MPI). An EPIC 4000 visual elec-
trodiagnostic testing system (LKC Technologies, Gaithersburg, 
MD, USA) with a CMGS-1 Color Mini-Ganzfeld Stimulator 
(LKC Technologies, Gaithersburg, MD, USA) was used to cap-
ture electroretinograms (ERG). The left eye was tested at each 
time point. The animals were dark adapted for 20 min, followed 
by a scotopic recording (single white flash 2.45  cd  s/m2, three 
technical replicates). Electroretinography was also performed on 
age-matched, genotype matched, non-inoculated control animals 
(n = 2 EE211, n = 2 EK211) to provide negative control values. 
Statistical analysis of ERGs was performed with GraphPad Prism 
6. Paired t-tests were used to compare ERG values across time 
points for each animal.
Optical coherence Tomography
Retinas were imaged 1  day prior to inoculation (0  MPI), at 
12 MPI, and prior to necropsy when animals displayed unequivo-
cal signs of clinical disease. A Bioptigen SD-OCT (Bioptigen, 
Durham, NC, USA) was used to capture linear B scans (6 mm; 
1000 A scans/B scan). Scans were taken from the central retina. 
At each time point at least 10 measurements per animal of retinal 
thickness were taken from multiple scan frames (using on-screen 
calipers) to determine an average thickness measurement for 
each animal. The values reported are ±standard deviation of the 
measurements. Retinal thickness was also measured for aged 
matched, genotype matched, non-inoculated control animals 
(n = 2 EE211, n = 2 EK211) to provide negative control values. 
Statistical analysis of optical coherence tomography (OCT) data 
was performed with GraphPad Prism 6. OCT data were grouped 
by time point and analyzed for differences between groups using 
the Mann–Whitney test.
histopathology
Vacuolation profiles were generated by examining 17 defined 
regions of brain on HE stained sections and scoring the severity of 
vacuolation as described previously (23). Neuroanatomical areas 
examined were as follows: nucleus of the solitary tract, nucleus 
of the spinal tract of the trigeminal nerve, hypoglossal nucleus, 
vestibular nuclear complex, cochlear nucleus, cerebellar vermis, 
central gray matter, rostral colliculus, medial geniculate nucleus, 
hypothalamus, nucleus dorsomedialis thalami, nucleus ventralis 
lateralis thalami, frontal cortex, septal nuclei, caudate nucleus, 
putamen, and claustrum.
immunohistochemistry
Immunohistochemistry was used to assess accumulation of PrPSc 
and, in the eye, the resulting response of retinal tissue.
Tissue sections from non-central nervous system tissues were 
immunostained by an automated immunohistochemical method 
for detection of PrPSc as described previously (10). Briefly, after 
deparaffinization and rehydration, tissue sections were auto-
claved for 30 min in an antigen retrieval solution (DAKO Target 
Retrieval Solution, DAKO Corp., Carpinteria, CA, USA) and 
stained with an indirect, biotin-free staining system containing 
an alkaline phosphatase labeled secondary antibody (ultraview 
Universal Alkaline Phosphatase Red Detection Kit, Ventana 
Medical Systems, Inc., Tucson, AZ, USA) designed for an auto-
mated immunostainer (NexES IHC module, Ventana Medical 
Systems, Inc., Tucson, AZ, USA). The primary antibody used was 
F99/97.6.1 [O’Rourke et al. (24), Pullman, WA, USA] at a concen-
tration of 10 μg/ml, and incubation was carried out at 37°C for 
32 min. Slides were counterstained with Gill’s hematoxylin and 
bluing agent (Ventana Medical Systems, Tucson, AZ, USA) then 
coverslipped.
Tissues sections from the brain, spinal cord, and eye were 
immunostained manually. After deparaffinization and rehydra-
tion, tissue sections were autoclaved at 100°C for 20  min in 
an antigen retrieval solution (Dako Target Retrieval Solution, 
Dako Corp., Carpinteria, CA, USA). Tissue sections were 
cooled, then washed, then immersed in methanol containing 
0.3% H2O2 for 20 min. Tissue sections were immunostained for 
PrPSc using the primary antibodies F99/97.6.1 at a concentration 
of 2 μg/ml, 6C2 [Rigter et al. (25), Central Veterinary Institute, 
Lelystad, Netherlands] at a concentration of 1  μg/ml, 12B2 
[Langeveld et  al. (26), Central Veterinary Institute, Lelystad, 
Netherlands], or R145 (eye only) (27) at a concentration of 
0.2  μg/ml. Incubation was carried out at 4°C overnight. A 
proprietary polymer (Dako polymer, Dako Corp., Carpinteria, 
CA, USA) linked to HRP was added for 10 min. The reaction 
was visualized using 3,3′-diaminobenzidine tetrachloride (DAB 
2, Vector Laboratories, Burlingame, CA, USA) as the chroma-
gen for 10  min. Slides were counterstained with hematoxylin, 
rehydrated, then coverslipped.
In the eye, immunoreactivity for rabbit anti-GFAP (DAKO, 
diluted at 1:7500) was visualized with an EnVision HRP-System 
as directed (DAKO). Images for the figures were captured using a 
Nikon DS camera on a Nikon Eclipse 50i microscope.
PrPSc profiles were generated by scoring the severity of defined 
morphological immunolabeling types in 10 brain regions at the 
level of the basal nuclei as described previously (28). Histological 
sections immunolabeled with the anti-prion protein antibody 
6C2 were used for this examination.
Molecular characterization
Western blotting on the BSE samples was performed as described 
previously (10). Briefly, brain homogenate was prepared in a 1× 
homogenization buffer (Prionics AG, Switzerland) and digested 
with proteinase K at 37°C for 1 h. Samples were diluted 1:4 in 
4× SDS-PAGE sample buffer and analyzed by standard western 
blotting procedures. Western blot detection was conducted using 
mouse anti-PrP monoclonal antibodies (mAb) 6H4 at a 10:000 
dilution (0.1 μg/ml), P4 at a 1:10,000 dilution (0.1 μg/ml), or 
SAF-84 at 1:200 dilution (1 μg/ml) as the primary antibody.
Deglycosylation of PrPres was performed as described previ-
ously (10). Briefly, 5–10  μl of 10% brain homogenate was PK 
digested as above and denatured in sodium dodecyl sulfate (final 
concentration 3% w/v) at 100°C for 10  min. The PK-digested, 
denatured homogenates (5–10 μl) were incubated with PNGase 
F (final concentration 150 U/μl) at 37°C for ≥16 h. The samples 
were combined with loading buffer and heated to 100°C for 5 min 
prior to gel electrophoresis.
TaBle 1 | animal data for challenged and control cattle.
animal  
number
inoculum genotype  
PRNP 211
survival  
time (MPi)
1 E211K BSE-H EK 9.8
2 E211K BSE-H EE 18.1
3 Classical BSE EK 25.8
4 Classical BSE EE 25.4
5 Non-inoculated EK n/a
6 Non-inoculated EE n/a
7 Non-inoculated EK n/a
8 Non-inoculated EE n/a
BSE, bovine spongiform encephalopathy; PRNP, prion protein gene; EE, glutamate 
glutamate (wild type polymorphism); EK, glutamate lysine; MPI, months post-
inoculation; n/a, not applicable.
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glycoprofile generation
The glycoprofile is based on the relative proportions of the 
unglycosylated, monoglycosylated, and diglycosylated PrPSc 
bands visible on western blot. PrPSc signals were analyzed with 
image-analysis software (ImageJ, National Institutes of Health) 
using seven technical replicates of the same brain homogenate 
per animal.
iDeXX elisa-Based PrPsc stability assays
Determination of PrPSc stability by the use of the IDEXX 
HerdChek BSE ELISA (in the absence of proteinase K digestion) 
was performed as described previously (29) with modifications to 
improve buffering with high concentrations of brain homogenate 
(30). Briefly, whole homogenates (lacking PK treatment) were 
prepared by beadbeating in Dulbecco’s PBS with 10X buffering 
strength, and homogenate samples were incubated with increas-
ing concentrations of guanidine hydrochloride (GdnHCl; 0.25–4 
or 0.25–5 M) for 1 h in 10× PBS. The level of PrPSc remaining at 
each (GdnHCl) was assessed immediately after sample dilution 
to 0.25 M GdnHCl by application to the HerdChek BSE ELISA 
plate. Values at each (GdnHCl) were normalized to the signal for 
a 0.25  M GdnHCl treatment point. Control samples included 
PrPSc from n = 3 non-E211K BSE-H cases [cases #5–7 in Table 1 
of (30)] and PrPSc from n = 4 BSE-C-infected cases [cases #1–4 in 
Table 1 of Ref. (30)]. Comparison of stability curves was based on 
the (GdnHCl)1/2 value, i.e., the concentration of GdnHCl required 
to reduce the level of the PrPSc signal by half compared to the 
0.25 M normalization point.
resUlTs
incubation Period
Survival times for BSE-C inoculated animals were similar 
(Table  1). For E211K BSE-H inoculated animals, the survival 
time for the EK211 animal, 9.8 months, was much shorter than 
that for the EE211 animal (18.1 months) (Table 1).
clinical signs
All challenged cattle developed clinical disease with survival 
times of between 9.8 and 25.8 MPI (Table 1). Clinical presenta-
tion of animal #1 (PRNP genotype EK211, challenged with E211K 
BSE-H) has been reported previously (10). Briefly, early clinical 
signs observed at 9.4 MPI included listlessness, low head carriage, 
and decreased feed consumption. One week later, animal #1 was 
separating himself from other animals in the pen, head press-
ing, intermittently reluctant to rise, and ataxic when moving. He 
began repetitive, excessive lip licking and sham chewing behav-
iors that were not associated with feeding. By 9.8 MPI, animal #1 
was depressed, salivating excessively, and reluctant to rise so was 
euthanized.
Animal #2 (EE211, E211K BSE-H) demonstrated a low head 
carriage, i.e., head down in non-physiologic position with droop-
ing ears, at 14.8  MPI. By 17.7  MPI animal #2 was listless, had 
begun head pressing, was reluctant to move, and showed forelimb 
ataxia. Approximately 2  weeks later (18.1  MPI) animal #2 was 
observed to be pacing in circles in the pen; walking in a figure 
eight motion and turning only when her nose or ears came in 
contact with a wall or gate. She was euthanized the next day.
Animal #3 (EK211, BSE-C) was noted to be hyper-responsive 
to sound at 14.6 MPI but was not ataxic at this time. Inappetance 
was first noted at 19.4 MPI and by 25.3 MPI animal #3 displayed 
distinct weight loss. A slight increase in startle response was 
noted at 20.2  MPI but did not progress. Equivocal ataxia was 
observed as early as 14.8 MPI and progressed to hopping of the 
hind legs (23.4 MPI), goose-stepping (25.3 MPI), and difficulty 
rising (25.8 MPI). Animal #3 was euthanized at 25.8 MPI.
The earliest unequivocal clinical signs displayed by animal #4 
(EE211, BSE-C) were an increase in startle response and decreased 
appetite at 19  MPI. Hyperreactivity increased and appetite 
decreased over the following 3 months and at 22 MPI animal #4 
began scratching and pressing her head against the wall or gate. 
Proprioceptive deficits and ataxia were noted at 24.3  MPI and 
distinct weight loss and abnormal licking and chewing behaviors 
at 25.3 MPI. One week later (25.4 MPI), animal #4 developed a 
head tremor and twitching, had difficulty rising and moved with 
a stumbling gait for a brief time after rising, and displayed hind-
limb ataxia and staggering when moving and turning. Animal #4 
was euthanized at that time.
electroretinography
Electroretinography is used to objectively measure retinal func-
tion by measuring several attributes of the resulting waveform. 
Here, electroretinography was used to assess any effects of 
host or inoculum genotype on retinal function during BSE 
incubation.
Analysis of b-wave implicit times show a prolongation of the 
b-wave implicit time in all animals between pre-inoculation 
(baseline) testing and testing at clinical end-point or 12 MPI. This 
prolongation was statistically significant in both E211K BSE-H 
inoculated cattle and the EE211 BSE-C inoculated animal, but 
not in the EK211 BSE-C inoculated animal (Table 2, Figure 1).
Optical coherence Tomography
To investigate the effect of host or inoculum genotype on retinal 
thickness during BSE incubation OCT was used to measure retinal 
thickness in vivo. Retinal thickness of experimental animals prior 
to inoculation was not significantly different than the control 
group values (Mann–Whitney test, P > 0.99) (Table 2). Retinal 
TaBle 2 | electroretinography (b-wave implicit time) and optical coherence tomography (retinal thickness) results for challenged and control cattle.
B-wave implicit time (milliseconds ± seM) retinal thickness (μm ± seM)
case number Pre-inoculation 6 MPi 9 MPi 12 MPi Pre-inoculation 12 MPi clinical control animals
1 26.7 (2.0) 36.7 (1.8) 65.0 (1.2)** n/a 371 (27) n/a 275 (6)
2 41.0 (0.9) 42.5 (0.5) 45.8 (4.7) 59.5 (2.5)** 287.6 (2.5) 259.8 (3.6) 270.4 (3.8)
3 33.5 (0.6) 41.5 (2.8) 32.7 (0.7) 44.2 (5.5) 325 (8.1) 270.7 (2.4) 275.1 (1.5)
4 28.5 (9.0) 25.8 (2.4) 44.7 (1.8) 45.2 (5.4)* 274.8 (12.3) 265.3 (3.1) 250.7 (2.0)
5 302.1 (3.9)
6 308.3 (5.9)
7 309.6 (3.3)
8 289.9 (2.9)
SEM, standard error of the mean of three technical replicates (B-wave implicit time) or 10 technical replicates (retinal thickness); MPI, months post-inoculation.
*P < 0.05.
**P < 0.001.
FigUre 1 | B-wave implicit times, measured using electroretinography, for challenged cattle. (a,B) E211K BSE-H challenged cattle, (a) PRNP genotype 
EE211and (B) PRNP genotype EK211. (c,D) classical BSE challenged cattle, (c) PRNP genotype EE211and (D) PRNP genotype EK211. MPI, months post 
inoculation. Stars indicate statistically significant differences between baseline data (collected 1 day prior to inoculation) and data collected at final examination: 
*P < 0.05, **P < 0.001.
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thickness in all BSE challenged animals decreased between pre-
inoculation testing and testing at 12 MPI, which was independent 
of incubation time.
One animal (case #1, EK211, E211K BSE-H) developed clini-
cal disease and was necropsied at 9.8 MPI so was not included in 
the 12 MPI test. For animal #2 (EE211, E211K BSE-H) and animal 
#3 (EK211, BSE-C), retinal thickness values at 12 MPI were not 
significantly different to those at clinical stages (paired t-test, both 
P > 0.1). However, for animal #4 (EE211, BSE-C) retinal thick-
ness at clinical stages was significantly thinner than at 12 MPI 
(P < 0.01). Retinal thickness of all challenged animals at clinical 
stages was significantly decreased compared to age-matched 
negative control animals (P = 0.03) (Table 2).
Vacuolation lesion Profiles
Some neuroanatomical areas of interest included in the Simmons 
et  al. (23) vacuolation profiling method were not available for 
examination in some cattle in this study. Therefore, when compar-
ing vacuolation lesions profiles, only the neuroanatomical areas 
that were available for examination in all cattle were included in 
FigUre 3 | Patterns of PrPsc immunoreactivity in the retina. (a,B) 
Prominent PrPSc immunoreactivity in retinal ganglion cells of E211K BSE-H 
challenged (a) EK211 and (B) EE211 cattle. Original magnification 10×. 
Inset: higher magnification view of ganglion cell immunoreactivity. Original 
magnification 40×. (c,D) PrPSc immunoreactivity in retinal ganglion cells is 
much less prominent in BSE-C challenged (c) EK211 and (D) EE211 cattle. 
Original magnification 10×. Inset: higher magnification view of ganglion cell 
immunoreactivity. Original magnification 40×. Abbreviations, retinal cell layers: 
OFL, optic fiber layer; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, 
inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; 
OLM, outer limiting membrane; OS, outer segments. Monoclonal anti-prion 
protein antibody F99/97.6.1.
FigUre 2 | Vacuolation lesion profiles. (a) BSE-C challenged cattle. (B) 
BSE-H challenged cattle. Neuroanatomical areas examined: 1, nucleus of the 
solitary tract; 2, nucleus of the spinal tract of the trigeminal nerve; 3, 
hypoglossal nucleus; 4, cerebellar vermis; 5, medial geniculate nucleus; 6, 
frontal cortex; 7, caudate nucleus; 8, putamen; 9, claustrum.
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the analysis, i.e., nucleus of the solitary tract, nucleus of the spinal 
tract of the trigeminal nerve, hypoglossal nucleus, cerebellar ver-
mis, medial geniculate nucleus, frontal cortex, caudate nucleus, 
putamen, and claustrum.
The vacuolation profiles for BSE-C inoculated cattle were very 
similar (Figure  2A). The vacuolation profiles for both E211K 
BSE-H challenged animals were also broadly similar (Figure 2B). 
Compared to BSE-C challenged animals, BSE-H challenged 
animals showed more severe vacuolation at the medulla at the 
level of the obex (nucleus of the solitary tract and hypoglossal 
nucleus), and in the frontal cortex.
immunohistochemistry
The brain, spinal cord (cervical, thoracic, and lumbar), and 
retina were positive in all cattle. The trigeminal ganglion was 
positive in the wild-type BSE-C challenged animal only. PrPSc 
was not present in any of the other tissues examined from any 
of the cattle.
PrPsc immunoreactivity in the retina
When using both the R145 and 99/97 anti-PrP antibodies, 
immunoreactivity was observed in the inner and outer plexiform 
(synaptic) layers in all animals (Figure 3). However, PrPSc immu-
noreactivity was different in the retinas of animals inoculated 
with classical BSE compared to animals inoculated with E211K 
BSE-H. Animals inoculated with E211K BSE-H had increased 
accumulation of PrPSc in cell bodies of retinal ganglion cells and 
in the outer limiting membrane. Appreciable PrPSc immunoreac-
tivity also was detected in the optic nerves of animals inoculated 
with E211K BSE-H, but not with animals inoculated with classi-
cal BSE.
gFaP immunoreactivity in the retina
GFAP immunoreactivity was observed in the optic nerve and 
optic fiber layer in astrocytes and in Müller glia endfeet. GFAP 
immunoreactivity was also observed throughout Müller glia 
in processes spanning the retina and terminating in the outer 
limiting membrane. There was no appreciable difference in 
GFAP immunoreactivity between any of the animals (data 
not shown).
FigUre 4 | aggregated and plaque-like deposits observed in the 
e211K Bse-h challenged wild type (ee211) animal. (a) Neocortex. 
Original magnification 5×. (B) Thalamus. Original magnification 20×. Arrow 
heads ►, aggregated PrPSc deposits. Arrow →, plaque-like PrPSc deposit. 
Note the lucent central area (core) which is present in the plaque-like 
deposits but not in the aggregated deposits.
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PrPsc immunoreactivity in the Brain
There was strong immunolabeling throughout the brain of 
the wild-type BSE-C animal (#4), including granular, linear, 
aggregated, intraneuronal, and stellate labeling types. There 
was moderately strong immunolabeling of the neocortex with 
prominent stellate and intra-glial labeling and less granular and 
intraneuronal labeling compared to the diencephalon (thalamus 
and hypothalamus), mesencephalon (midbrain) and rhom-
bencephalon (medulla, pons, cerebellum). In the cerebellum, 
prominent stellate and linear labeling types were seen in the 
molecular layer, and fine granular to aggregated immunolabe-
ling in the granular layer (Figure S1 in Supplementary Material). 
Compared to the wild-type BSE-C animal, the magnitude of 
immunolabeling was decreased in the EK211 animal (#3), 
particularly in the lenticular nuclei and neocortex. In addition, 
granular and stellate labeling types were relatively less promi-
nent, and neocortical labeling was less severe and comprised 
mostly stellate labeling with mild granular labeling. Only very 
mild fine granular immunolabeling was present in the cerebellar 
cortex, although moderate granular, linear, and intraneuronal 
labeling was observed in the cerebellar nuclei.
H-type BSE challenged cattle demonstrated very little (#2 
EE211) or no (#1 EK211) membrane associated labeling (linear, 
perineuronal) in the rhombencephalon. Small aggregates were 
present throughout the brain in animal #2, but only from the 
mesencephalon (especially in the substantia nigra) and rostrally in 
animal #1. The most striking feature of immunolabeling in animal 
#2 was large aggregates and plaque-like deposits in the diencepha-
lon and rostrally; these deposits were particularly prominent in 
the neocortical white matter (Figure 4). In both BSE-H challenged 
cattle stellate labeling was only observed in the lenticular nuclei 
and neocortex. Patterns of immunolabeling in the cerebellum 
were broadly similar but with subtle differences: linear labeling 
was present in the molecular layer of animal #2, and granular 
labeling in the granular layer was more severe in animal #1.
PrPsc lesion Profiles
Due to differences in neuroanatomical areas sampled, some 
features were not present in all cases. Therefore, the immuno-
labeling types associated with these features (ependymal and 
subependymal) were omitted from the final comparison of PrPSc 
profiles. PrPSc profiles assessed at the level of the basal nuclei 
were broadly similar for BSE-H challenged cattle and BSE-C 
challenged cattle (Figure 5), although there were a number of 
points of difference. For BSE-C challenged cattle, the EE211 
animal had a more intra-astrocytic and stellate labeling than the 
EK211 animal. For BSE-H challenged cattle, the EE211 animal 
had prominent non-vascular plaque-like deposits, particularly in 
the white matter, that were not observed in the EK211 animal or 
BSE-C challenged cattle.
Molecular characterization
On western blots labeled with mAb 6H4 (Figure 6A), brainstem 
samples from BSE-C and E211K BSE-H challenged cattle showed 
the characteristic three-band pattern profile of PrPSc. In both 
BSE-C and E211K BSE-H challenged cattle, the signal for the 
diglycosylated band was stronger than the unglycosylated or 
monoglycosylated bands. Migration of the unglycosylated band 
of E211K BSE-H samples was higher than BSE-C samples. When 
cerebellum samples were examined using mAb 6H4, a fourth 
band migrating at ~23 kDa was present in the cerebellum from 
animal #1 (EK211, E211K BSE-H) (Figure 6B, arrow). This addi-
tional band was not present in cerebellum samples from other 
cattle in this study.
On western blots of brainstem labeled with mAb P4 
(Figure  6C), BSE-H samples showed the characteristic three-
band pattern profile, while no detectable PrPSc was observed for 
BSE-C samples. Using mAb SAF-84 (Figure 6D), samples from 
both BSE-C and BSE-H challenged cattle showed the character-
istic three-band pattern profile of PrPSc. In BSE-H cases, there is a 
fourth band at 14 kDa (Figure 6D) that also was present following 
deglycosylation (Figure 6E).
The majority of the PrPSc in all cattle was diglycosylated 
(average 78%), with smaller amounts of the monoglycosylated 
FigUre 5 | PrPsc lesion profiles. Legend names indicate challenge inocula and PRNP 211 genotype. PrPSc morphological immunolabeling types: ITNR, 
intraneuronal; ITAS, intra-astrocytic; ITMG, intramicroglial; STEL, stellate; SBPL, subpial; PRVS, perivascular; PVAC, perivacuolar; PART, particulate/coalescing; 
PNER, perineuronal; LINR, linear; NVPL, non-vascular plaques; VSPL, vascular plaques.
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(15%) and unglycosylated (7%) PrPSc. When the percentage of 
diglycosylated to monoglycosylated PrPSc was plotted, BSE-C 
challenged cattle were found to be similar to each other and dif-
ferent to BSE-H challenged cattle (Figure 7).
iDeXX elisa-Based PrPsc stability assays
To test for biophysical differences between PrPSc of a particular 
combination of inoculum and genotype, stability was determined 
by unfolding in GdnHCl. In a previous study, PrPSc from animal 
#1 (animal #25 in that publication) was shown to be more resistant 
to denaturation than PrPSc from animal #4 (animal #26) consist-
ent with their assignments as BSE-H and BSE-C, respectively, by 
western blot (30). Stability curves for an E211K BSE-H animal 
were consistent with the stability curves for multiple non-E211K 
BSE-H animals (30).
To expand this analysis, we characterized the GdnHCl stabil-
ity profiles of PrPSc from animal #2 (EE211, E211K BSE-H) and 
animal #3 (EK211, BSE-C). The animal #3 sample exhibited lower 
stability [lower (GdnHCl)1/2 value] with a profile consistent with 
the BSE-C control (Figure  8A, circles). The animal #2 sample 
exhibited higher stability [higher (GdnHCl)1/2 value], with a 
profile consistent with the BSE-H control (Figure 8A, triangles).
When we compared the stability profiles for all four animals 
in this study (Figure 8B), curves from animals #1 and #2 (E211K 
BSE-H challenged cattle) generally cluster in the denaturation part 
of the curve, as do curves #3 and #4 (BSE-C challenged cattle). 
Variation in the initial region of the curve has previously been 
observed in non-proteinase K processed livestock samples (29, 30).
Results of GdnHCl stability curves support the findings of the 
western blotting on these brain homogenates. That is, samples 
with a western blot pattern characteristic of BSE-C also produce 
a GdnHCl stability profile (i.e., lower stability) consistent with 
BSE-C, regardless of PRNP genotype at codon 211. Similarly, 
samples from EK211 or wild-type cattle with a western blot pat-
tern characteristic of BSE-H produce a GdnHCl stability profile 
(i.e., higher stability) consistent with BSE-H.
DiscUssiOn
In this study, we investigated the role of the E211K polymorphism 
and its interaction with disease phenotype in animals inoculated 
with classical BSE or BSE-H from an animal with the E211K poly-
morphism (E211K BSE-H). The results presented here extend on 
previous published results of challenge of an EK211 calf with 
E211K BSE-H (10) by including data from the challenge of wild-
type cattle with E211K BSE-H, and challenge of EK211 and wild-
type (EE211) cattle with BSE-C. Overall, inoculum strain had a 
greater effect on disease phenotype than host genotype, although 
some differences were observed between cattle challenged with 
the same inoculum, in particular among the E211K BSE-H chal-
lenged cattle. However, due to the small number of animals in this 
study, biological variation between individual animals may have 
contributed to the observed differences.
The phenotype of BSE-C was similar in EK211 and wild-type 
cattle with regard to almost all parameters tested. For example, 
the incubation periods (31, 32) (Hawkins, unpublished data) and 
vacuolation profiles (33, 34) of both BSE-C challenged animals 
were similar to each other, and consistent with previous studies 
of cattle challenged with classical BSE via the intracranial route. 
These results are consistent with the observation that BSE-C is 
FigUre 6 | Western blot analysis using a panel of monoclonal 
antibodies. (a) Analysis of brainstem samples using monoclonal antibody 
(mAb) 6H4. The unglycosylated (lowest) band migrates higher in samples 
from E211K BSE-H challenged cattle (#1 and #2, PRNP genotypes EK211 
and EE211, respectively) than in BSE-C challenged cattle (#3 and #4, PRNP 
genotypes EK211 and EE211, respectively). The diglycosylated bands are 
more prominent than the unglycosylated or monoglycosylated bands. (B) 
Analysis of cerebellum samples using mAb 6H4. Note the presence of an 
additional band at approximately 23 kDa in animal #1 (arrow). (c) Analysis 
using monoclonal antibody P4. Samples from BSE-H challenged cattle (#1 
and #2) show the characteristic 3-band profile while no detectable PrPSc is 
observed for BSE-C samples (#3 and #4). (D) Analysis using mAb SAF-84. 
Note the presence of a 4th band at ~14 kDa in samples from BSE-H 
challenged cattle (#1 and #2) that is not present in BSE-C challenged cattle 
(#3 and #4). (e) Analysis using mAb SAF-84 after PNGase F treatment. There 
is an unglycosylated fragment at ~20 kDa, which is present in all cattle. In 
addition, samples from BSE-H challenged cattle present a second band at 
~14 kDa. Samples were loaded at 0.5–1.0 mg equivalent of brain tissue per 
lane. Molecular weight standards (MW) flank the blots and the molecular 
weight in kiloDalton is indicated to the left of the blot.
FigUre 7 | relative amounts of mono- and diglycosylated PrPsc in 
brain homogenates from challenged cattle. Triangles represent BSE-H 
challenged cattle, circles represent BSE-C challenged cattle. Open triangle 
and open circle are cattle with the EK211 genotype. Closed triangle and 
closed circle are cattle with the EE211 genotype. Error bars represent the SE 
of the mean of seven technical replicates.
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caused by a single prion strain with reliably consistent biological 
characteristics (35, 36).
One point of difference was that the wild type, but not the 
EK211 animal, developed abnormal licking and chewing behav-
iors in the clinical phase of disease. These behaviors were similar 
to those observed in the EK211 animal challenged with E211K 
BSE-H (10). The lack of any clear inoculum or genotype associa-
tion with the abnormal licking and chewing behaviors suggests 
that it is possible that they are part of the spectrum of biological 
variation in the clinical presentation of BSE. A second point of dif-
ference was that the EE211 BSE-C challenged animal developed 
statistically significant changes in retinal function and thickness 
that were not as severe as in the EK211 BSE-C challenged animal.
In contrast to the relatively homogeneous phenotype observed 
in BSE-C challenged cattle, a number of striking differences were 
observed between the EK211 and wild-type cattle challenged 
with E211K BSE-H.
The incubation time for the wild-type animal (18 MPI) was 
similar to that reported for cattle challenged IC with BSE-H iso-
lates from France (16.5–21 MPI) (37, 38), Canada (15–16 MPI) 
(34), or Germany (14–16 MPI) (39). The clinical duration of the 
wild-type animal (3.3  months) falls within the average clinical 
duration for BSE-H of 2–4.5 months reported in previous studies 
(34, 37–39). Interestingly, the incubation period for the EK211 
animal (9.8 MPI) was just 55% of that of the wild-type animal 
challenged with the same inoculum and the clinical duration 
(2 weeks) was also very short. This supports our hypothesis that 
cattle with the E211K polymorphism are predisposed to a rapid 
onset of BSE-H when exposed (10).
Prominent large aggregates and plaque-like accumulations 
of PrPSc were observed in the wild-type animal that is consist-
ent with previous reports for BSE-H challenged cattle (34, 37). 
These immunolabeling types were not observed in the E211K 
animal (or BSE-C challenged cattle). Both E211K BSE-H chal-
lenged cattle showed characteristic PrPSc accumulation in retinal 
ganglion cells and a significant increase in b-wave implicit time, 
significant retinal thinning compared to age-matched controls, 
as has been reported previously for E211K and wild-type BSE-H 
cases (10, 40).
The K211 allele did not affect the molecular profile of PrPSc 
in BSE-C challenged cattle and, thus, would not mask the pres-
ence of feedborne BSE-C. PrPSc from the brainstem at the level 
of the obex showed a similar western blot migration pattern in 
the two E211K BSE-H challenged cattle. However, the relative 
amounts of mono- versus diglycosylated PrPSc in these samples 
were different, with values for the EK211 animal lying midway 
between the wild-type EK211 BSE-H challenged animal and the 
two BSE-C challenged animals. Furthermore, on western blot 
FigUre 8 | stability properties of Bse isolates. (a) Comparison of PrPSc 
stabilities of heterologous inoculum-host genotype isolates. Animal #2 (PRNP 
EE211 challenged with E211K BSE-H), BSE-H (non-E211K H-type BSE), 
animal #3 (EK211 challenged with BSE-C), BSE-C (classical (E211E) BSE). 
Curves for animals #2 and #3 reflect average values of five technical 
replicates for each animal. Curves for BSE-C and BSE-H reflect average 
values of at least three biological replicates, with error bars on each of these 
two curves representing SE of the mean. (B) Stability properties of BSE 
isolates from challenged cattle. Animal #1 (EK211 challenged with E211K 
BSE-H), animal #2 (EE211 challenged with E211K BSE-H), animal #3 (EK211 
challenged with BSE-C), animal #4 (EE211 challenged with BSE-C). Curves 
for all animals reflect average values of 3–5 technical replicates. GdnHCl 
stability curves in (a,B) were plotted based on normalization to the 0.25 M 
treatment point.
10
Moore et al. Experimental E211K H-Type BSE
Frontiers in Veterinary Science | www.frontiersin.org September 2016 | Volume 3 | Article 78
of cerebellum, an additional band was observed in the EK211 
animal challenged with E211K BSE-H but not the wild-type 
animal. These differences in the molecular characteristics appear 
to be genotype, rather than inoculum, driven and further work 
is needed to determine the molecular explanations for these 
observations.
Previously, we demonstrated that BSE-C and BSE-H cattle 
brain homogenates can be discriminated by their resistance to 
denaturation in GdnHCl in a whole homogenate, ELISA-based 
stability assay (30). Specifically, BSE-H PrPSc is more resistant 
to denaturation in GdnHCl than BSE-C PrPSc. Data from the 
present study support our previous findings. In addition, stability 
curves for cattle that received the same inoculum were similar to 
each other, regardless of PRNP genotype, and even in the case of 
heterologous inoculum-host genotype combinations, the stability 
curve of the recipient was similar to the inoculum isolate, rather 
than the homologous genotype inoculum isolate.
The bovine E211K PRNP polymorphism is homologous to 
the human E200K mutation that is associated with fCJD (41). 
Therefore, we considered possible similarities between the epi-
demiology and phenotypic expression of prion disease in EK200 
humans and EK211 cattle.
The human E200K mutation accounts for >70% of cases of 
fCJD (42), while the bovine E211K polymorphism has only been 
detected in a single case (8) out of the ~60 cases of atypical BSE-H 
diagnosed to date (43). The E211K polymorphism is very rare 
in cattle; it has not been detected in cattle tested in the United 
States (n = 6062 cattle tested) (44), China (n = 349) (45), Poland 
(46), or Pakistan (n = 236 cattle and n = 281 buffalo) (47). We 
currently have non-inoculated heterozygous and homozygous 
K211 cattle under observation for the potential development of 
genetic BSE-H.
On western blot, an additional fragment in PrPSc from cerebel-
lum has been reported in an E200K-129V CJD case (48). This 
band migrates at 17 kDa in contrast to the 23 kDa additional band 
observed in the cerebellum from the E211K BSE-H challenged 
EK211 animal in this study (10). With regard to immunohisto-
chemistry, the characteristic stripe-like immunolabeling in the 
molecular layer of the cerebellar cortex reported in E200K CJD 
cases (4) was not observed in cattle in this study. Nor was “type 
III” intraneuronal immunoreactivity (small, globular, 1.5–4.0 μm 
diameter, darkly immunostained, intracytoplasmic PrPSc accu-
mulations), which has been significantly associated with a subset 
of E200K fCJD cases (49).
Due to the rarity of the E211K polymorphism in cattle and the 
small number of cases of prion disease in E211K cattle available 
for examination at this time, further work is needed to determine 
the relationship between prion disease associated with the E211K 
bovine polymorphism and the human E200K mutation.
In this study, we have demonstrated that, in EK211 and wild-
type cattle challenged with BSE-C or E211K BSE-H, inoculum 
strain has a greater effect on disease phenotype than host genotype. 
The phenotype of E211K BSE-H remains stable when transmitted 
to cattle without the K211 polymorphism, although a number of 
differences were observed between the EK211 compared to the 
wild-type animal. In addition, the phenotype of E211K BSE-H 
shows a number of features that allow it to be differentiated from 
BSE-C in both wild-type and heterozygous animals.
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